Abbott Launches World?s First Dual-Chamber Leadless Pacemaker System in India
Abbott launches the world’s first AVEIR dual-chamber leadless pacemaker in India, enabling proper heart rhythm without wires or surgical pockets.
Abbott | 06/10/2025 | By Dineshwori
Abbott Introduces FreeStyle Libre 2 Plus: Continuous Glucose Monitoring Without Fingersticks
Abbott, a global healthcare leader, has launched the FreeStyle Libre 2 Plus sensor in India, a device that delivers automatic glucose readings every minute directly to a user’s smartphone. The innovation aims to provide people living with diabetes greater confidence, precision, and ease in managing their condition.
Abbott | 22/08/2025 | By Darshana | 178
Abbott Introduces Lab-Based Blood Test to Help Evaluate Mild Traumatic Brain Injury
The diagnostic tool also helps eliminate the need for CT scans by up to 40 percent with a high degree of certainty eliminating wait time at the hospital and unnecessary exposure to radiation.
Abbott | 25/06/2025 | By Darshana | 175
Abbott Secures CE Mark for its Volt Pulsed Field Ablation System to Treat Patients with AFib
With the earlier-than-expected CE Mark, Abbott has begun commercial PFA cases in the EU with physicians who have already gained experience with the Volt PFA System within Abbott's PFA clinical studies.
Abbott | 31/03/2025 | By Aishwarya | 303
Abbott Inaugurates New Global Manufacturing Facility in Ireland
The Kilkenny facility is part of a EUR 440 million investment in Ireland, which includes a significant expansion of the company’s Donegal site, where a further 200 jobs are being created.
Abbott | 19/11/2024 | By Aishwarya | 521
Abbott Launches New Technology to Support Advanced Cardiac Mapping
Abbott's investigational Volt PFA System was designed to overcome prior limitations in PFA systems by pairing a balloon-in-basket catheter with Abbott's EnSits X EP System, an heart mapping solution.
Abbott | 11/10/2024 | By Aishwarya | 386
Abbott Announces Availability of Lingo Continuous Glucose Monitor in US
Lingo is based on Abbott's world-leading FreeStyle Libre continuous glucose monitoring technology, now used by more than 6 million people with diabetes globally.
Abbott | 06/09/2024 | By Aishwarya | 521
Abbott Signs Global Partnership with Medtronic for Insulin Delivery Devices
Abbott has inked a global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's most advanced, FreeStyle Libre technology that will connect with Medtronic's automated insulin delivery (AID) and smart insulin pen systems.
Abbott | 08/08/2024 | By Aishwarya | 365
Powder formulas, Similac, Alimentum & EleCare manufactured at Michigan plant are recalled by Abbott
Abbott is voluntarily recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility
Abbott | 20/02/2022 | By Darshana | 515
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy